John Celebi
2021
In 2021, John Celebi earned a total compensation of $6.9M as President and Chief Executive Officer at Sensei Biotherapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $264,000 |
---|---|
Option Awards | $6,116,715 |
Salary | $487,068 |
Other | $41,912 |
Total | $6,909,695 |
Celebi received $6.1M in option awards, accounting for 89% of the total pay in 2021.
Celebi also received $264K in non-equity incentive plan, $487.1K in salary and $41.9K in other compensation.
Rankings
In 2021, John Celebi's compensation ranked 1,784th out of 12,415 executives tracked by ExecPay. In other words, Celebi earned more than 85.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,784 out of 12,415 | 86th |
Division Manufacturing | 662 out of 5,508 | 88th |
Major group Chemicals And Allied Products | 247 out of 2,378 | 90th |
Industry group Drugs | 208 out of 2,099 | 90th |
Industry Pharmaceutical Preparations | 142 out of 1,549 | 91st |
Source: SEC filing on June 15, 2023.
Celebi's colleagues
We found two more compensation records of executives who worked with John Celebi at Sensei Biotherapeutics in 2021.